Podrobný výpis o publikaci

ŠTOURAČ, Pavel, Jana BEDNÁŘOVÁ, Pavel ZICHACEK, Zdena CERMAKOVA, Zbysek PAVELEK a Martin VALIS. Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice. NEUROLOGICAL SCIENCES. New York: Springer, 2022, roč. 43, č. 1, s. 687-690. ISSN 1590-1874. Dostupné z: https://dx.doi.org/10.1007/s10072-021-05563-x.

Další formáty: BibTeX LaTeX RIS

Základní údaje
Originální název	Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice
Autoři	ŠTOURAČ, Pavel (203 Česká republika, garant, domácí), Jana BEDNÁŘOVÁ (203 Česká republika, domácí), Pavel ZICHACEK (203 Česká republika), Zdena CERMAKOVA (203 Česká republika), Zbysek PAVELEK (203 Česká republika) a Martin VALIS (203 Česká republika).
Vydání	NEUROLOGICAL SCIENCES, New York, Springer, 2022, 1590-1874.

Další údaje
Originální jazyk	angličtina
Typ výsledku	Článek v odborném periodiku
Obor	30210 Clinical neurology
Stát vydavatele	Itálie
Utajení	není předmětem státního či obchodního tajemství
WWW	URL
Impakt faktor	Impact factor: 3.300
Kód RIV	RIV/00216224:14110/22:00125087
Organizační jednotka	Lékařská fakulta
Doi	http://dx.doi.org/10.1007/s10072-021-05563-x
UT WoS	000687902800001
Klíčová slova anglicky	Autoimmune and limbic encephalitis; Anti-N-methyl-D-aspartate receptor antibodies
Štítky	14110221
Příznaky	Mezinárodní význam, Recenzováno
Změnil	Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 1. 2. 2022 10:25.

Anotace
Autoimmune and limbic encephalitides are still rare diseases characterized by rapid diagnostics and treatment development in recent years. The incidence of anti-N-methyl-D- aspartate receptor [NMDAR] encephalitis is about 1.5 per million person per year, and the incidence of paraneoplastic neurological syndromes [PNS] including limbic encephalitis [LE] is about 1.22 per 100 000 person per year (Vogrig et al. J Neurol 267:26-35, 1; Dalmau et al. Ann Neurol 61:25-36, 2). The diagnostic criteria of anti-NMDAR encephalitis are already well established (Zuliani et al. Neurol Sci 40:2017-2030, 10). We provide immunological and clinical characteristics of anti-NMDAR encephalitis case series emphasizing unusual association with colon tumour in one case and complete recovery in two cases. Then we report two cases of onconeural and cell surface antibody negative limbic encephalitis [LE] associated with tumours, seizures, cognitive and behavioural changes resulting in severe cerebellar syndrome and fatal outcome. The clinical characteristics and results of selected paraclinical examinations as electroencephalography [EEG], magnetic resonance imaging [MRI] and cerebrospinal fluid [CSF] analysis are reviewed.

Anotace

Autoimmune and limbic encephalitides are still rare diseases characterized by rapid diagnostics and treatment development in recent years. The incidence of anti-N-methyl-D- aspartate receptor [NMDAR] encephalitis is about 1.5 per million person per year, and the incidence of paraneoplastic neurological syndromes [PNS] including limbic encephalitis [LE] is about 1.22 per 100 000 person per year (Vogrig et al. J Neurol 267:26-35, 1; Dalmau et al. Ann Neurol 61:25-36, 2). The diagnostic criteria of anti-NMDAR encephalitis are already well established (Zuliani et al. Neurol Sci 40:2017-2030, 10). We provide immunological and clinical characteristics of anti-NMDAR encephalitis case series emphasizing unusual association with colon tumour in one case and complete recovery in two cases. Then we report two cases of onconeural and cell surface antibody negative limbic encephalitis [LE] associated with tumours, seizures, cognitive and behavioural changes resulting in severe cerebellar syndrome and fatal outcome. The clinical characteristics and results of selected paraclinical examinations as electroencephalography [EEG], magnetic resonance imaging [MRI] and cerebrospinal fluid [CSF] analysis are reviewed.